Oncogenesis Following Delivery of a Nonprimate Lentiviral Gene Therapy Vector to Fetal and Neonatal Mice
Open Access
- 1 October 2005
- journal article
- research article
- Published by Elsevier
- Vol. 12 (4) , 763-771
- https://doi.org/10.1016/j.ymthe.2005.07.358
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLoS Biology, 2004
- Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vectorFEBS Letters, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Transcription Start Regions in the Human Genome Are Favored Targets for MLV IntegrationScience, 2003
- Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectorsMolecular Therapy, 2003
- New Methods to Titrate EIAV-Based Lentiviral VectorsMolecular Therapy, 2002
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002
- Efficient Gene Delivery and Targeted Expression to HepatocytesIn Vivoby Improved Lentiviral VectorsHuman Gene Therapy, 2002
- Stable gene transfer to the nervous system using a non-primate lentiviral vectorGene Therapy, 1999
- Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosisNature, 1981